Soroka University Medical Center
Beersheba, 84101, Israel
NCT Number: NCT00753558
There is an urgent need to control our current national outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP). The purpose of this study is to eradicate CRKP gastrointestinal carriage using selective digestive decontamination (SDD); with buccal and oral gentamicin and polymyxin E administration. This will reduce infections and hopefully mortality caused by CRKP.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Beersheba, 84101, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Arm #1: Oral gentamicin & polymyxin E, gentamicin & polymyxin E buccal gel.
Arm #2: Oral placebo solutions, placebo buccal gel.
Time frame: Two days after treatment ends
Time frame: Six weeks
Soroka University Medical Center
Other
A Randomized,Double-Blind,Placebo-Controled Trial of Selective Digestive Decontamination Using Oral Gentamicin and Oral Polymyxin E for Eradication of Carbapenem-Resistant Klebsiella Pneumoniae Carriage
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.